November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Intramuscular Naloxone May Match IV Delivery for Methadone Overdose with Fewer Withdrawal Symptoms

🧠 AI Analysis 2 min read 👁 0

A clinical trial comparing naloxone administration routes found intramuscular delivery equally effective at restoring breathing while causing less severe withdrawal than intravenous treatment.

Intramuscular Naloxone May Match IV Delivery for Methadone Overdose with Fewer Withdrawal Symptoms🧠AI Analysis

Photo: Nature Health Sciences

Key points

  • A clinical trial of 160 patients in Iran evaluated intramuscular versus intravenous naloxone for methadone overdose.
  • Both administration methods demonstrated similar rates of recovery for breathing and consciousness.
  • Intramuscular delivery was linked to less severe withdrawal symptoms and lower four-hour heart rates.

A randomized clinical trial involving 160 hospitalized patients in Tehran, Iran, suggests that intramuscular naloxone may reverse methadone overdoses as effectively as intravenous administration while triggering less severe opioid withdrawal symptoms. The study, published in Nature Health Sciences, evaluated adult patients aged 19 to 59 with suspected methadone toxicity to compare the two drug delivery routes following initial stabilization.

Researchers observed that both delivery methods achieved comparable rates of recovery in respiratory rate and consciousness level, with 50.8% of patients in the intramuscular group and 49.2% in the intravenous group showing normalization. However, patients who received intravenous naloxone recorded significantly higher Clinical Opiate Withdrawal Scale scores, indicating more severe acute withdrawal. Additionally, the intramuscular group maintained a lower median heart rate of 76 beats per minute at four hours post-treatment compared to 98 beats per minute in the intravenous group. Apnea occurred in 25% of intramuscular cases and 22.5% of intravenous cases, with each instance successfully treated using a single rescue dose.

What to know: Intramuscular naloxone may represent a reasonable alternative in medical settings where establishing intravenous access is difficult or delayed. However, the trial authors noted several limitations, including the single-center setting, potential variability in dosing, unverified co-ingested substances, and a lack of confirmatory toxicological screening. Patients and caregivers should consult medical professionals for personal advice and treatment planning regarding opioid use disorders.

Source Nature Health Sciences — nature.com/articles/s41598-026-64972-0 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.